site stats

Genelux corporation stock

WebGenelux Corporation is committed to developing safe and effective next-generation immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Our goal is to ensure access to our … WebSep 25, 2024 · SAN DIEGO, Sept. 25, 2024 /PRNewswire/ -- Genelux Corporation, a privately-held clinical-stage immunotherapy company, today announced that it has entered into a convertible note and warrant ...

Genelux Corporation (GNLX) Stock Price, News, Quote & History

WebThere are 24.55 M shares outstanding in Genelux Corporation Registered Shs, which values the company at $659.22 M. Genelux Corporation Registered Shs Stock … WebContact Email [email protected]. Phone Number 8584830026. Genelux Corporation is a privately-held, clinical stage biopharmaceutical company that has developed a proprietary oncolytic virus based technology platform and a deep pipeline of products with broad applications for cancer detection and therapy. GL-ONC1 the company’s lead oncology ... long overcoat india wedding wear https://ppsrepair.com

Genelux Corporation - GNLX - Stock Price Today - Zacks

WebWhat we know about the Genelux Corporation IPO. Genelux Corporation filed a registration form with the US Securities and Exchange Commission (SEC) to go public on the Nasdaq Capital Market under the ticker symbol GNLX. Not yet an official IPO, this is one of the first steps of taking a private company public. When is Genelux Corporation … WebJan 26, 2024 · All of the shares are being offered by Genelux. In addition, Genelux has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares … WebApr 10, 2024 · Balance Sheet. The company has $397,000 in cash and $26.09 million in debt, giving a net cash position of -$25.69 million or -$1.05 per share. Cash & Cash Equivalents. 397,000. Total Debt. 26.09M. Net Cash. -25.69M. Net Cash Per Share. hope falls series

Genelux Corporation - GNLX - Stock Price Today - Zacks

Category:GNLX Interactive Stock Chart Genelux Corporation Stock

Tags:Genelux corporation stock

Genelux corporation stock

Genelux - Crunchbase Company Profile & Funding

WebApr 11, 2024 · As of Tuesday, April 11, Genelux Corp’s GNLX share price has surged by 7.54%, which has investors questioning if this is right time to sell. My Portfolio. ... Why Genelux Corp’s (GNLX) Stock Is Up 7.54%. By Jack Gilleland April 11, 2024 . Featured Tickers: GNLX. None FREE REPORT. Top Tech Stocks ... WebView Genelux Corp (GNLX) stock price today, market news, streaming charts, forecasts and financial information from FX Empire.

Genelux corporation stock

Did you know?

WebApr 11, 2024 · – On March 29, leaders of Genelux Corp. (NASDAQ: GNLX) based in Westlake Village rang the opening bell for the Nasdaq stock market in Times Square, New York City. The ceremony, broadcast live from the Nasdaq MarketSite Tower, included company co-founder and director Dr. John Thomas who is also a board director of Small … WebApr 10, 2024 · 1 Wall Street analysts have issued twelve-month target prices for Genelux's shares. Their GNLX share price forecasts range from $10.00 to $10.00. On average, …

Web1 day ago · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ... WebGenelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from …

WebApr 11, 2024 · A high-level overview of Genelux Corporation (GNLX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebCompany profile page for Genelux Corp including stock price, company news, press releases, executives, board members, and contact information

WebApr 8, 2024 · GNLX Stock Overview. Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. About the company

WebGenelux Corp stock price yesterday was $29.68. What is the PE ratio of Genelux Corp? The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. long overcoat mens greyWebDec 31, 2024 · Genelux Corporation reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 11.07 … long overcoat designs for ladiesWebApr 12, 2024 · Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from … long overflow vbaWebSep 21, 2024 · The Investor Relations website contains information about Genelux Corporation's business for stockholders, potential investors, and financial analysts. Skip … long overcoats for womenWebApr 4, 2024 · View Genelux Corporation GNLX investment & stock information. Get the latest Genelux Corporation GNLX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. long overdue outstandinglong overcoat sims 4 ccWebApr 11, 2024 · Genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share range, for its stock market debut Thursday on the Nasdaq under the … Detailed statistics for Genelux Corporation (GNLX) stock, including valuation … Detailed financial statements for Genelux (GNLX), including the income statement, … 2 months ago - Genelux Corporation Announces Pricing of Initial Public … hopefamily